Movement Alert｜METiS Pharmaceuticals-P Declines 5.08% in Regular Trading, Post-IPO Pullback Continues as New Stock Enthusiasm Fades

Market Focus05-29

On May 29, METiS Pharmaceuticals-P fell 5.08% in regular trading, trading at HK$15.31 per share, with trading volume of HK$17.89 million.

On the news front, METiS Pharmaceuticals, known as the world's first AI drug delivery company to go public, listed on the Hong Kong Stock Exchange on May 13 at an IPO price of HK$10.50 and surged 173% on its debut. However, the stock has been in sustained retreat over multiple consecutive trading sessions since listing, pulling back significantly from its first-day high.

The company remains in the early stages of commercialization, having accumulated approximately RMB 1.5 billion in losses over the past three years with volatile revenue, leaving its growth outlook uncertain. Additionally, some internationally placed shares carry no lock-up period, generating persistent profit-taking pressure. Although the company recently launched its AiProtein platform and announced a strategic alliance with Deerfield to co-develop next-generation in vivo protein therapeutics and immunotherapies, post-IPO market enthusiasm continues to cool rapidly, sustaining downward pressure on the share price.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190305195?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-29 11:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190305195","market":"hk","top_or_hot":-1,"title":"Movement Alert｜METiS Pharmaceuticals-P Declines 5.08% in Regular Trading, Post-IPO Pullback Continues as New Stock Enthusiasm Fades","media":"Market Focus","content":"<p><p>On May 29, METiS Pharmaceuticals-P fell 5.08% in regular trading, trading at HK$15.31 per share, with trading volume of HK$17.89 million.</p><p>On the news front, METiS Pharmaceuticals, known as the world's first AI drug delivery company to go public, listed on the Hong Kong Stock Exchange on May 13 at an IPO price of HK$10.50 and surged 173% on its debut. However, the stock has been in sustained retreat over multiple consecutive trading sessions since listing, pulling back significantly from its first-day high.</p><p>The company remains in the early stages of commercialization, having accumulated approximately RMB 1.5 billion in losses over the past three years with volatile revenue, leaving its growth outlook uncertain. Additionally, some internationally placed shares carry no lock-up period, generating persistent profit-taking pressure. Although the company recently launched its AiProtein platform and announced a strategic alliance with Deerfield to co-develop next-generation in vivo protein therapeutics and immunotherapies, post-IPO market enthusiasm continues to cool rapidly, sustaining downward pressure on the share price.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜METiS Pharmaceuticals-P Declines 5.08% in Regular Trading, Post-IPO Pullback Continues as New Stock Enthusiasm Fades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜METiS Pharmaceuticals-P Declines 5.08% in Regular Trading, Post-IPO Pullback Continues as New Stock Enthusiasm Fades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-29 11:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 29, METiS Pharmaceuticals-P fell 5.08% in regular trading, trading at HK$15.31 per share, with trading volume of HK$17.89 million.</p><p>On the news front, METiS Pharmaceuticals, known as the world's first AI drug delivery company to go public, listed on the Hong Kong Stock Exchange on May 13 at an IPO price of HK$10.50 and surged 173% on its debut. However, the stock has been in sustained retreat over multiple consecutive trading sessions since listing, pulling back significantly from its first-day high.</p><p>The company remains in the early stages of commercialization, having accumulated approximately RMB 1.5 billion in losses over the past three years with volatile revenue, leaving its growth outlook uncertain. Additionally, some internationally placed shares carry no lock-up period, generating persistent profit-taking pressure. Although the company recently launched its AiProtein platform and announced a strategic alliance with Deerfield to co-develop next-generation in vivo protein therapeutics and immunotherapies, post-IPO market enthusiasm continues to cool rapidly, sustaining downward pressure on the share price.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1190305195","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190305195","pubTimestamp":1780024128,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 29, METiS Pharmaceuticals-P fell 5.08% in regular trading, trading at HK$15.31 per share, with trading volume of HK$17.89 million.On the news front, METiS Pharmaceuticals, known as the world's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"动向提示|METiS Pharmaceuticals-P常规交易下跌5.08%新股热情消退IPO后回调持续","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"On May 29, METiS Pharmaceuticals-P fell 5.08% in regular trading, trading at HK$15.31 per share, with trading volume of HK$17.89 million.On the news front, METiS Pharmaceuticals, known as the world's first AI drug delivery company to go public, listed on the Hong Kong Stock Exchange on May 13 at an IPO price of HK$10.50 and surged 173% on its debut. However, the stock has been in sustained retreat over multiple consecutive trading sessions since listing, pulling back significantly from its first-day high.The company remains in the early stages of commercialization, having accumulated approximately RMB 1.5 billion in losses over the past three years with volatile revenue, leaving its growth outlook uncertain. Additionally, some internationally placed shares carry no lock-up period, generating persistent profit-taking pressure. Although the company recently launched its AiProtein platform and announced a strategic alliance with Deerfield to co-develop next-generation in vivo protein therapeutics and immunotherapies, post-IPO market enthusiasm continues to cool rapidly, sustaining downward pressure on the share price.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190305195","isCrawlerRequest":true}